Kevin Koch, the President and CEO of Edgewise Therapeutics , Inc. (NASDAQ:EWTX), a biotechnology company with a market capitalization of $2.5 billion, recently executed a series of stock transactions, ...

Russell Alan J, the Chief Scientific Officer of Edgewise Therapeutics , Inc. (NASDAQ:EWTX), executed a series of stock transactions recently, as detailed in a recent SEC filing. On February 5 and 6, ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Prolonged exposure to microgravity in space weakens the heart muscle and disrupts the heart’s rhythm, Johns Hopkins ...

A pioneer of cardiac surgery Dr KM Cherian, credited with performing the country’s first heart bypass surgery in 1975, died on Saturday. He was 82. He is remembered for performing challenging heart ...

Maturation and functionality of cardiac cell types were determined by several criteria, including contractile force and relaxations measured by analyzing pole deflection, well-defined sarcomere ...

India’s preeminent cardiac surgeon K.M. Cherian, who performed India’s first coronary bypass surgery, died in Bengaluru on Saturday (January 25, 2025). Only a couple of days ago his biography ...

Females with hypertrophic cardiomyopathy present at a more advanced stage of the disease and have a higher risk of heart failure and death. The factors behind these differences are unclear. We aimed ...

Robert Blaustein, M.D., Ph.D., joins the Company as Chief Development Officer, responsible for leading EDG-7500, a novel cardiac sarcomere modulator in Phase 2 development, as well as the ...